Masao Nakagawa

12PUBLICATIONS
31CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 25, 2026
Genome-wide CRISPR screens identify an RXR-MYLIP-LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas.

|Jul 13, 2026
PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

|Nov 12, 2025
The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.

Wei Wei, Zhihui Song, Yajun Wang

|May 02, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.

Yuta Ito, Joji Shimono, Keisuke Kawamoto

|Dec 24, 2023
Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.

Masahiro Chiba, Joji Shimono, Keito Suto

|Jun 20, 2023
Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.

Zhihui Song, Wenjun Wu, Wei Wei

Pageof 2

Frequent Collaborators

8 joint publications

Takanori Teshima

7 joint publications

Yibin Yang

7 joint publications

Masahiro Chiba

5 joint publications

Keito Suto